Disgraced at Vertex, Ian Smith’s career implosion ends with swift exile from biotech boards
Ian Smith’s biopharma career went over a cliff on January 23rd when Vertex abruptly fired him for unexplained “personal behavior” the executive crew found unacceptable. Exile followed as his board seats quickly began to tumble after that.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
